Notice: Clinical trials for medical devices and drugs relating to COVID-19 regulations

The Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations (Regulations) were published on March 2, 2022. They came into effect on February 27, 2022, following the repeal of Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19 (IO No. 2).

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:56 (UTC)
Created April 17, 2026, 17:56 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2022-03-02 00:00:00
open_canada_keywords {"fr": ["avis", "essais cliniques", "dispositifs médicaux", "médicaments", "réglementation COVID-19", "abrogation de l'ordonnance provisoire n°"], "en": ["notice", "clinical trials", "medical devices", "drugs", "COVID-19 regulations", "repeal of Interim-Order-No. 2"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis : Règlement sur les essais cliniques d’instruments médicaux et de drogues liés à la COVID-19
update_frequency as_needed